Starting capital
€199,347 2,000 shares
Mountvector Bio
Lifetime
1 annual account with figurespeak -€24,837 (2025)
-€24,837
lowest -€24,992 (2025)
-€24,992
peak €174,355 (2025)
€174,355
€6,061
Board2 names since 2024
2 directors and 1 other
Documentsfilings and deeds
28-08-202628 days late
2025micro format
Loss of €24,992Registered office moved from Liège to Ottignies-Louvain-la-Neuve 26-08First year with figures
Key points
from the 2025 annual accountsPosition in the sector
96.6%
Higher solvency than 92% of companies in pharmaceuticals. Sector median 45.9% · 88 companies.
2025 accounts filed 28 days after the deadlineTurnover not published (micro format)
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 3,234 companies had the same profile as Mountvector Bio has now. Each dot stands for 9 companies, two years later.
87.5%
were still trading
9.0%
stopped another way
3.3%
went bankrupt
Another 0.2% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 3,234 companies, not a prediction for Mountvector Bio. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1015077878
Registered office moved from Liège to Ottignies-Louvain-la-Neuve
New registered office: Fond des Més, 5/18 à 1348 Ottignies-Louvain-la-Neuve · Previous registered office: Avenue de I'Hôpital, 11 à 4000 Liège · General meeting of 30-05-2025 · Gazette deed
Incorporation
Founding capital of €199,347.36, 2,000 shares · Founder: · Appointments: (director) and (director) · published on 16-10-2024 · Gazette deed
First establishment
Mountvector Bio SRL, Avenue de l'Hôpital 11, Liège
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Mountvector Bio Ottignies-Louvain-la-Neuve | €180,416 | -€24,837 | 96.6% | - |
| RODILO Liège | €204,587 | -€2,254 | -43.9% | - |
| Groovy.Bio Evergem | €744,069 | -€17,721 | 73.2% | 0.2 |
| FYTOBELL Hasselt | €122,152 | -€55,562 | -322.9% | - |
| BIOMDRIN Schilde | €38,268 | €4,129 | 58.3% | - |
| RTLC Brussels | €107,167 | -€66 | 61.9% | - |
| HUVESEARCH Pelt | €95,955 | €1,033 | 59.9% | - |
These companies have the same main activity as Mountvector Bio: manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21201). They are comparable in size and age: total assets between €38,300 and €744,000, founded between 2010 and 2024.
Official details
Source: KBO- Status
- Active since 14-10-2024Normal situation
- Registered office
- 12 active companies are registered at this address1 started in the 12 months before. Source: KBO register, as of 13 November 2026.
- Activity
- Manufacture of basic pharmaceutical products and pharmaceutical preparationsNACE 21201
- Establishment unit
- 2.367.582.2354000 Liège, since 14-10-2024
- Financial year end
- 31 December
- Peppol
- Reachable since 09-12-2025
Insights on Mountvector Bio
Mountvector Bio has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €174,355 and a net result of -€24,992.
Its solvency ranks better than 93% of 88 sector peers (NACE 21, financial year 2025).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Mountvector Bio
- What is the company number of Mountvector Bio?
- The company number of Mountvector Bio is 1015.077.878. The VAT number is the same number with BE in front: BE 1015.077.878.
- Where is Mountvector Bio based?
- The registered office is at Fond des Més 5, 1348 Ottignies-Louvain-la-Neuve.Company details
- What does Mountvector Bio do?
- According to the KBO register, the main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21201).
- What is the legal form of Mountvector Bio?
- Mountvector Bio is a private limited company (BV).
- When was Mountvector Bio founded?
- Mountvector Bio was founded on 14-10-2024.
- Is Mountvector Bio still active?
- Yes, Mountvector Bio is an active enterprise in the KBO register.
- What is the turnover of Mountvector Bio?
- The annual accounts for financial year 2025 state no turnover. The micro format does not require it.Financials
- Is Mountvector Bio profitable?
- In financial year 2025, Mountvector Bio made a loss of €24,992.
- Where can I find the annual accounts of Mountvector Bio?
- Mountvector Bio filed 1 annual account with the National Bank of Belgium, for financial year 2025.
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark Estimate what this company is worth.Value indication
See how customers, suppliers and banks see your own company and what to improve first.